المؤلفون: Ronald F van Vollenhoven, Sander W Tas, Taco W Kuijpers, Maarten Boers, Michael T Nurmohamed, Gertjan Wolbink, Irene E van der Horst-Bruinsma, Theo Rispens, Willem Lems, Alexandre Voskuyl, Carla A Wijbrandts, S Marieke van Ham, Martijn Gerritsen, Erik H Vogelzang, Luuk Wieske, Laura Boekel, Femke Hooijberg, Yaëlle R Besten, Maureen Leeuw, Sadaf Atiqi, C Krieckaert, Bas Dijkshoorn, Siham Bakhlakh, Juliette J Crooijmans, Filip Eftimov, Laura Y Kummer, PJ Koos van Dam, Eileen W Stalman, Maurice Steenhuis, Sofie Keijzer, Olvi Cristianawati, Jim Keijser, Floris C Loeff

المصدر: RMD Open, Vol 8, Iss 1 (2022)

مصطلحات موضوعية: Medicine

وصف الملف: electronic resource

Relation: https://rmdopen.bmj.com/content/8/1/e002035.full; https://doaj.org/toc/2056-5933

URL الوصول: https://doaj.org/article/c31dbe2993a2456ab42dc303970a81d9

المؤلفون: Laura Boekel, Femke Hooijberg, Erik H Vogelzang, Yaëlle R Besten, Maureen Leeuw, Sadaf Atiqi, Ronald F van Vollenhoven, Carla A Wijbrandts, Martijn Gerritsen, C Krieckaert, Bas Dijkshoorn, Siham Bakhlakh, Juliette J Crooijmans, Alexandre Voskuyl, Irene E van der Horst-Bruinsma, Willem Lems, Taco W Kuijpers, S Marieke van Ham, Luuk Wieske, Filip Eftimov, Laura Y Kummer, PJ Koos van Dam, Eileen W Stalman, Maurice Steenhuis, Sofie Keijzer, Olvi Cristianawati, Jim Keijser, Floris C Loeff, Sander W Tas, Michael T Nurmohamed, Maarten Boers, Theo Rispens, Gertjan Wolbink

المساهمون: Clinical Immunology and Rheumatology, AII - Inflammatory diseases, AMS - Musculoskeletal Health, Landsteiner Laboratory, Paediatric Infectious Diseases / Rheumatology / Immunology, ARD - Amsterdam Reproduction and Development, Neurology, ANS - Neuroinfection & -inflammation, Graduate School, Paediatrics, Experimental Immunology, EURO-NMD, Rheumatology, APH - Societal Participation & Health, Medical Microbiology and Infection Prevention, AMS - Tissue Function & Regeneration, ACS - Atherosclerosis & ischemic syndromes, Epidemiology and Data Science, APH - Methodology

المصدر: Rheumatic & Musculoskeletal Diseases Open, 8, 1
RMD open, 8(1):002035. BMJ Publishing Group
Rheumatic & Musculoskeletal Diseases Open, 8
RMD Open, 8(1):002035. BMJ Publishing Group
Boekel, L, Hooijberg, F, Vogelzang, E H, Besten, Y R, Leeuw, M, Atiqi, S, van Vollenhoven, R F, Wijbrandts, C A, Gerritsen, M, Krieckaert, C, Dijkshoorn, B, Bakhlakh, S, Crooijmans, J J, Voskuyl, A, van der Horst-Bruinsma, I E, Lems, W, Kuijpers, T W, van Ham, S M, Wieske, L, Eftimov, F, Kummer, L Y, van Dam, P K, Stalman, E W, Steenhuis, M, Keijzer, S, Cristianawati, O, Keijser, J, Loeff, F C, Tas, S W, Nurmohamed, M T, Boers, M, Rispens, T & Wolbink, G 2022, ' Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases : data from a prospective cohort study ', RMD Open, vol. 8, no. 1, 002035 . https://doi.org/10.1136/rmdopen-2021-002035

مصطلحات موضوعية: Adult, History, Polymers and Plastics, antirheumatic agents, SARS-CoV-2, Immunology, COVID-19, Severity of Illness Index, Industrial and Manufacturing Engineering, Rheumatology, biological therapy, Rheumatic Diseases, Inflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5], Immunology and Allergy, Humans, autoimmune diseases, epidemiology, Prospective Studies, Business and International Management

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1435379ab158ca7d4c0cf06c2e660c43

المؤلفون: M. Leeuw, S. Atiqi, F. De Vries, L. Boekel, F. Hooijberg, M. Nurmohamed, G. J. Wolbink, C. Krieckaert

المصدر: Annals of the Rheumatic Diseases. 81:1104.1-1105

مصطلحات موضوعية: Rheumatology, Immunology, Immunology and Allergy, General Biochemistry, Genetics and Molecular Biology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::7e97d78f0bc4e0ecd6074a15f50b3c76
https://doi.org/10.1136/annrheumdis-2022-eular.1009

المؤلفون: S. Atiqi, M. Leeuw, F. Hooijberg, L. Boekel, F. Loeff, K. Bloem, C. Krieckaert, A. De Vries, M. Nurmohamed, T. Rispens, G. J. Wolbink

المصدر: Annals of the Rheumatic Diseases. 81:601.2-602

مصطلحات موضوعية: Rheumatology, Immunology, Immunology and Allergy, General Biochemistry, Genetics and Molecular Biology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::0a87e0120a81dd05797bdfa57cd7318c
https://doi.org/10.1136/annrheumdis-2022-eular.4701

المؤلفون: Gertjan Wolbink, R. F. van Vollenhoven, J. Ruwaard, Michael T. Nurmohamed, M. J. L `Ami, Theo Rispens, C. Krieckaert

المساهمون: Clinical Immunology and Rheumatology, AII - Inflammatory diseases, AMS - Ageing & Morbidty, Landsteiner Laboratory, Rheumatology, ACS - Atherosclerosis & ischemic syndromes

المصدر: l’ Ami, M J, Ruwaard, J, Krieckaert, C L M, Nurmohamed, M T, van Vollenhoven, R F, Rispens, T & Wolbink, G J 2019, ' Serum drug concentrations to optimize switching from adalimumab to etanercept in rheumatoid arthritis ', Scandinavian Journal of Rheumatology, vol. 48, no. 4, pp. 266-270 . https://doi.org/10.1080/03009742.2019.1577915
Scandinavian journal of rheumatology, 48(4), 266-270. Informa Healthcare
Scandinavian Journal of Rheumatology, 48(4), 266-270. Informa Healthcare

مصطلحات موضوعية: Drug, Adult, Male, musculoskeletal diseases, medicine.medical_specialty, Necrosis, media_common.quotation_subject, Immunology, Gastroenterology, Etanercept, Arthritis, Rheumatoid, 03 medical and health sciences, 0302 clinical medicine, Rheumatology, Internal medicine, medicine, Adalimumab, Immunology and Allergy, Humans, 030212 general & internal medicine, Registries, skin and connective tissue diseases, media_common, Netherlands, 030203 arthritis & rheumatology, business.industry, Drug Substitution, Tumor Necrosis Factor-alpha, Patient Selection, food and beverages, General Medicine, Serum concentration, Middle Aged, medicine.disease, Blockade, Treatment Outcome, Rheumatoid arthritis, Antirheumatic Agents, Tumor necrosis factor alpha, Female, medicine.symptom, Drug Monitoring, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c6026d3d2ac45b0b1a3444ac07ba119
https://research.vumc.nl/en/publications/7d684d16-22f2-43fb-8e77-df1af7b17746

المؤلفون: Annick de Vries, Lea C. Berkhout, Michael T. Nurmohamed, Merel J l'Ami, Femke Hooijberg, Sadaf Atiqi, Theo Rispens, Gertjan Wolbink, C. Krieckaert

المصدر: Poster Presentations.

مصطلحات موضوعية: medicine.medical_specialty, Ankylosing spondylitis, business.industry, Radioimmunoassay, medicine.disease, Gastroenterology, Rheumatology, Golimumab, Psoriatic arthritis, Interquartile range, Rheumatoid arthritis, Internal medicine, medicine, Adalimumab, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::33fc4a926387397620f0c9a9924b8a4c
https://doi.org/10.1136/annrheumdis-2019-eular.1908

المؤلفون: C. Krieckaert, Sadaf Atiqi, Gertjan Wolbink, Merel J l'Ami, Lea C. Berkhout, Michael T. Nurmohamed, Femke Hooijberg, Annick de Vries, Theo Rispens

المصدر: Abstracts Accepted for Publication.

مصطلحات موضوعية: medicine.medical_specialty, medicine.diagnostic_test, business.industry, medicine.disease, Rheumatology, Etanercept, Quartile, Interquartile range, Therapeutic drug monitoring, Rheumatoid arthritis, Internal medicine, medicine, Adalimumab, Trough level, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::597b19bc2ec8230a070ec99e11c34aa8
https://doi.org/10.1136/annrheumdis-2019-eular.4098

المؤلفون: L. Burgemeister, J.C. van Denderen, G.J. Wolbink, A W R van Kuijk, Merel J l'Ami, Femke Hooijberg, C. Krieckaert, E. Kneepkens, Michael T. Nurmohamed, J. Ruwaard, Maarten Boers

المصدر: Annals of the Rheumatic Diseases. 79:130-130

مصطلحات موضوعية: medicine.medical_specialty, Ankylosing spondylitis, business.industry, Immunology, medicine.disease, General Biochemistry, Genetics and Molecular Biology, law.invention, Etanercept, Discontinuation, Psoriatic arthritis, Rheumatology, Randomized controlled trial, law, Blood drug, Rheumatoid arthritis, Internal medicine, medicine, Immunology and Allergy, Dosing, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::98176b40c56869f63a60bb3decd4bef2
https://doi.org/10.1136/annrheumdis-2020-eular.1320

المؤلفون: C. Krieckaert, C. Bastida, Z. Layegh, Alwin D. R. Huitema, T. Rispens, G.J. Wolbink, Michael T Nurmohamed, M. J. L `Ami

المصدر: Saturday, 16 JUNE 2018.

مصطلحات موضوعية: medicine.medical_specialty, medicine.diagnostic_test, business.industry, medicine.disease, Gastroenterology, Rheumatology, chemistry.chemical_compound, Tocilizumab, chemistry, Therapeutic drug monitoring, Interquartile range, Internal medicine, Rheumatoid arthritis, medicine, Trough Concentration, Prospective cohort study, business, Adverse effect

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::95fd0f4b3d048939ab232052f223540b
https://doi.org/10.1136/annrheumdis-2018-eular.6393

المؤلفون: W.A. van Leeuwen, T. Rispens, Erik H Vogelzang, Roeland Wieringa, M. Hart, A. de Vries, C. Krieckaert, Ninotska I. L. Derksen, G.J. Wolbink, Lea C. Berkhout, Michael T. Nurmohamed

المصدر: THURSDAY, 14 JUNE 2018.

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, biology, business.industry, Immunogenicity, Radioimmunoassay, medicine.disease, Certolizumab, Gastroenterology, humanities, Neutralization, 03 medical and health sciences, 030104 developmental biology, Internal medicine, Rheumatoid arthritis, biology.protein, medicine, Adalimumab, Tumor necrosis factor alpha, Antibody, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::adcae3db7608c7b16a408f9104e4aab0
https://doi.org/10.1136/annrheumdis-2018-eular.4399